Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 8,224 shares at $18.91 ($156K) on 2020-09-09, disclosed to the SEC on 2020-09-10.
Open-market sale of $156k FREQ by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.91 | 3,724 | $70K | 45.2% |
| 2 | $18.91 | 3,724 | $70K | 45.2% |
| 3 | $19.26 | 776 | $15K | 9.6% |
| Total | $18.94 avg | 8,224 | $156K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-25 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |